BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2424132)

  • 1. Small cell carcinoma of the lung--to operate or not? Surgical experience and results.
    Maassen W; Greschuchna D
    Thorac Cardiovasc Surg; 1986 Apr; 34(2):71-6. PubMed ID: 2424132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection in the management of small cell carcinoma of the lung.
    Shields TW; Higgins GA; Matthews MJ; Keehn RJ
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):481-8. PubMed ID: 6289013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
    Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of surgical and multimodality treatment for small cell bronchial carcinoma.
    Karrer K; Shields TW; Denck H; Hrabar B; Vogt-Moykopf I; Salzer GM
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):168-76. PubMed ID: 2536867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications.
    McCaughan BC; Martini N; Bains MS; McCormack PM
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):836-41. PubMed ID: 2987619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapy.
    Meyer JA; Ikins PM; Gullo JJ; Comis RL; Burke WA; DiFino SM; Parker FB
    J Thorac Cardiovasc Surg; 1984 Feb; 87(2):283-90. PubMed ID: 6319829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there ever a role for salvage operations in limited small-cell lung cancer?
    Shepherd FA; Ginsberg R; Patterson GA; Feld R; Goss PE; Pearson FG; Todd TJ; Winton T; Rubinger M; Johansen E
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):196-200. PubMed ID: 1846927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer.
    Shepherd FA; Ginsberg RJ; Evans WK; Feld R; Cooper JD; Ilves R; Todd TR; Pearson FG; Waters PF; Baker MA
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):498-506. PubMed ID: 6312199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
    Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indication for surgery in small-cell carcinoma of the lung.
    Kaiser D; Fritzsche A; Matthiesen W
    Thorac Cardiovasc Surg; 1992 Aug; 40(4):185-9. PubMed ID: 1329265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical therapy for carcinoma of the lung.
    Shields TW
    Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of T and N stages on long-term survival in resectable small cell lung cancer.
    Angeletti CA; Macchiarini P; Mussi A; Basolo F
    Eur J Surg Oncol; 1989 Aug; 15(4):337-40. PubMed ID: 2547663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for cure followed by combined modality treatment for small cell bronchial carcinoma. ISC Lung Cancer Study Group.
    Karrer K; Denck H; Karnicka-Mlodkowska H; Drings P; Erzen J; Dell'Amore D; Thermann M; Salzer GM; Sun Y; Liao ML
    Int J Clin Pharmacol Res; 1988; 8(6):415-21. PubMed ID: 2855325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of surgical resection in the management of small cell carcinoma of the lung.
    Ohta M; Hara N; Ichinose Y; Motohiro A; Takeo S; Miyake J
    Jpn J Clin Oncol; 1986 Sep; 16(3):289-96. PubMed ID: 3022037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical indication for T1N2 disease: comparison of survival among resected T1N2, T2 N2 and non-resected T1 (M0) disease].
    Hara N; Ichinose Y; Kuda T; Asoh H; Yano T; Kawasaki M; Sato K; Takamori S; Shibuya K; Ota M
    Kyobu Geka; 1991 Jan; 44(1):4-7. PubMed ID: 1645420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.